Cargando…
HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE(-/-) Mice: Evidence of ABCA1 Down-Regulation
OBJECTIVE: CER-001 is a novel engineered HDL-mimetic comprised of recombinant human apoA-I and charged phospholipids that was designed to mimic the beneficial properties of nascent pre-ß HDL. In this study, we have evaluated the dose-dependent regulation of ABCA1 expression in vitro and in vivo in t...
Autores principales: | Tardy, Claudine, Goffinet, Marine, Boubekeur, Nadia, Cholez, Guy, Ackermann, Rose, Sy, Gavin, Keyserling, Constance, Lalwani, Narendra, Paolini, John F., Dasseux, Jean-Louis, Barbaras, Ronald, Baron, Rudi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559410/ https://www.ncbi.nlm.nih.gov/pubmed/26335690 http://dx.doi.org/10.1371/journal.pone.0137584 |
Ejemplares similares
-
P2Y13 Receptor Regulates HDL Metabolism and Atherosclerosis In Vivo
por: Goffinet, Marine, et al.
Publicado: (2014) -
Development of CER-001: Preclinical Dose Selection Through to Phase I Clinical Findings
por: Keyserling, Constance H., et al.
Publicado: (2017) -
Non-clinical development of CER-001
por: Barbaras, Ronald
Publicado: (2015) -
Beneficial effects of recombinant CER-001 high-density lipoprotein infusion in sepsis: results from a bench to bedside translational research project
por: Stasi, Alessandra, et al.
Publicado: (2023) -
The HDL mimetic CER‐001 remodels plasma lipoproteins and reduces kidney lipid deposits in inherited lecithin:cholesterol acyltransferase deficiency
por: Pavanello, Chiara, et al.
Publicado: (2021)